Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Berman

Showing results (961-970 of 1,020) with videos related to

Pageof 102
Sort By:
Journal of Oncology Practice|May 2, 2012
Patterns of care for non-small-cell lung cancer at an academic institution affiliated with a national cancer institute-designated cancer centerKim-Son H Nguyen, Rachel A Sanford, Mark S Huberman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanomaSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Cancer Medicine|February 28, 2015
HER2 as a target in invasive urothelial carcinomaJoaquim Bellmunt, Lillian Werner, Aristotle Bamias, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Dasatinib nephrotoxicity correlates with patient-specific pharmacokineticsBenjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 29, 2023
Patient-Specific Pharmacokinetics and Dasatinib NephrotoxicityBenjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2021
Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timingNorma S Kenyon, Melissa A Willman, Dongmei Han, et al.
Transplantation|August 19, 2007
Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass modelDora M Berman, Over Cabrera, Norman M Kenyon, et al.
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.
Nucleic Acids Research|October 12, 2010
EMDataBank.org: unified data resource for CryoEMCatherine L Lawson, Matthew L Baker, Christoph Best, et al.
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Pageof 102

Showing results (961-970 of 1,020) with videos related to

Sort By:
Pageof 102
Journal of Oncology Practice|May 2, 2012
Patterns of care for non-small-cell lung cancer at an academic institution affiliated with a national cancer institute-designated cancer centerKim-Son H Nguyen, Rachel A Sanford, Mark S Huberman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanomaSteven A Rosenberg, Richard M Sherry, Kathleen E Morton, et al.
Cancer Medicine|February 28, 2015
HER2 as a target in invasive urothelial carcinomaJoaquim Bellmunt, Lillian Werner, Aristotle Bamias, et al.
Medrxiv : the Preprint Server for Health Sciences|May 3, 2023
Dasatinib nephrotoxicity correlates with patient-specific pharmacokineticsBenjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 29, 2023
Patient-Specific Pharmacokinetics and Dasatinib NephrotoxicityBenjamin O Adegbite, Matthew H Abramson, Victoria Gutgarts, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 19, 2021
Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timingNorma S Kenyon, Melissa A Willman, Dongmei Han, et al.
Transplantation|August 19, 2007
Interference with tissue factor prolongs intrahepatic islet allograft survival in a nonhuman primate marginal mass modelDora M Berman, Over Cabrera, Norman M Kenyon, et al.
Cancer Research|September 16, 2010
Cancer-related epigenome changes associated with reprogramming to induced pluripotent stem cellsJoyce E Ohm, Prashant Mali, Leander Van Neste, et al.
Nucleic Acids Research|October 12, 2010
EMDataBank.org: unified data resource for CryoEMCatherine L Lawson, Matthew L Baker, Christoph Best, et al.
Cancer Medicine|May 22, 2014
FGFR3 expression in primary and metastatic urothelial carcinoma of the bladderElizabeth A Guancial, Lillian Werner, Joaquim Bellmunt, et al.
Pageof 102